FDA Authorizes Marketing of 22nd Century Group’s VLN® as a Modified Risk Tobacco Product
VLN® Cigarettes VLN® King & VLN® Menthol King VLN® Is World’s First and Only Combustible Cigarette to Receive FDA MRTP…
Pharmaceuticals, Biotechnology and Life Sciences
VLN® Cigarettes VLN® King & VLN® Menthol King VLN® Is World’s First and Only Combustible Cigarette to Receive FDA MRTP…
Saint Herblain (France), December 23, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced…
New website (www.Rethink-ALZ.com) is intended to increase visibility and information for potential study participants.Rethink-ALZ.com connects patients with nearest participating clinical…
FDA approved the removal of the boxed warning from the TYMLOS label, effective December 22, 2021The boxed warning had referred…
– Topline results from pivotal SEAL study expected in Q1 2022 – If approved, ADAIR will target the growing Adderall®…
Researchers around the world can utilize the synthetic genome to produce virus to test strain-specific diagnostics, monoclonal antibody treatments, small-molecule…
WESTLAKE VILLAGE, Calif., Dec. 23, 2021 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing…
Leveraging AI to Accelerate the Path From Diagnosis to CureCAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Dec. 23, 2021 (GLOBE…
CEO Gerald Commissiong is also scheduled to appear on BNC at 1:50PM EST to discuss the authorization of Pfizer’s COVID…
EMERYVILLE, Calif., Dec. 23, 2021 (GLOBE NEWSWIRE) — XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board…